Friday, June 26, 2020 2:14:21 AM
never mind the market cap...its meaningless...kim is not diluting a defined number of shares....hes going to sell as many shares as necessary to get to $24 mil bucks...
the amount of shares that takes could be far more than anyone here is anticipating...even if things go well, kim is diluting the crap out of shares...best case scenario, it will likely be closer to 20%...
20% dilution in a short period of time?...no big deal?....are you kidding me???...it doesn't matter if you can find other companies that have done worse...all-time chart bs doesn't help either...
"The only thing that I hoped for in this situation differently would have been to have a Milliken step in to do this to join the ride up."
yes I know...and like I said...Milliken is a potential customer of kblb's...they are a potential buyer of their product...they are not financiers, they will not cough up any money to help save kblb, they will not buy them out and they will not ride in on a white horse and save the damsel in distress...
that's not who they are nor what they do...
everytime kim does any kind of deal with a company, within 3 minutes, dozens of posters claim to have fabulous d/d indicating that that company is going to take kblb under their wing and lead them to the promised land with all kinds of funding and emotional support...lol
it happened with sial, Warwick, the army, polartec and now Maxim...
maxim is going to help kblb sell a butt load of shares on the open market...cause that's what they do...
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM